Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy

首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy

【24h】

Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy

机译：妇科癌症患者的生活质量转归于化疗期间的综合肿瘤治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Integrative oncology incorporates complementary medicine (CM) therapies in patients with cancer. We explored the impact of an integrative oncology therapeutic regimen on quality-of-life (QOL) outcomes in women with gynecological cancer undergoing chemotherapy.

机译：肿瘤综合疗法结合了癌症患者的补充医学（CM）治疗。我们探讨了综合肿瘤治疗方案对接受化疗的妇科癌症妇女生活质量（QOL）结果的影响。

著录项

来源
《Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer》 |2015年第12期|共9页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类护理学;
关键词
Integrative medicine; Gynecologic oncology; Quality of life; Chemotherapy; Complementary medicine;

机译：中西医结合;妇科肿瘤;生活质量;化学疗法;辅助医学;

相似文献

外文文献
中文文献
专利

1. Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy [J] . Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2015,第12期

机译：妇科癌症患者的生活质量转归于化疗期间的综合肿瘤治疗
2. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study (vol 151, pg 18, 2018) [J] . Olawaiye Alexander B., Java James J., Krivak Thomas C., Gynecologic Oncology: An International Journal . 2019,第1期

机译：辅助化疗剂量修饰是否对患者患者患者的结果产生了影响？ NRG肿瘤学/妇科肿瘤学群体研究（第151卷，PG 18,2018）
3. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study [J] . Olawaiye Alexander B., Java James J., Krivak Thomas C., Gynecologic Oncology: An International Journal . 2018,第1期

机译：辅助化疗剂量修饰是否对患者患者患者的结果产生了影响？ NRG肿瘤学/妇科肿瘤学团体研究
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. A cost-utility analysis of an NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected Quality-of-life scores in an economic model of treatment of ovarian cancer [O] . David E Cohn, Jason C Barnett, Lari Wenzel, -1

机译：NRG肿瘤学/妇科肿瘤学组协议218的成本-效用分析：将前瞻性收集的生活质量评分纳入治疗卵巢癌的经济模型
7. Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131) [O] . Shin Nishio, Satomi Aihara, Mototsugu Shimokawa, 2018

机译：PalonoSetron加上地塞米松在预防化疗诱导的妇科化疗接受Carboplatin的化疗中的化疗诱导的恶心和呕吐的疗效：西日本妇科肿瘤学群体研究（WJGog 131）

Quality-of-life outcomes in patients with gynecologic cancer referred to integrative oncology treatment during chemotherapy

摘要

著录项

相似文献

相关主题

期刊订阅